165 related articles for article (PubMed ID: 17611545)
1. The disappearing Barr body in breast and ovarian cancers.
Pageau GJ; Hall LL; Ganesan S; Livingston DM; Lawrence JB
Nat Rev Cancer; 2007 Aug; 7(8):628-33. PubMed ID: 17611545
[TBL] [Abstract][Full Text] [Related]
2. BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin.
Pageau GJ; Hall LL; Lawrence JB
J Cell Biochem; 2007 Mar; 100(4):835-50. PubMed ID: 17146760
[TBL] [Abstract][Full Text] [Related]
3. Heterochromatin instability in cancer: from the Barr body to satellites and the nuclear periphery.
Carone DM; Lawrence JB
Semin Cancer Biol; 2013 Apr; 23(2):99-108. PubMed ID: 22722067
[TBL] [Abstract][Full Text] [Related]
4. Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells.
Sirchia SM; Ramoscelli L; Grati FR; Barbera F; Coradini D; Rossella F; Porta G; Lesma E; Ruggeri A; Radice P; Simoni G; Miozzo M
Cancer Res; 2005 Mar; 65(6):2139-46. PubMed ID: 15781624
[TBL] [Abstract][Full Text] [Related]
5. The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer.
Chaligné R; Popova T; Mendoza-Parra MA; Saleem MA; Gentien D; Ban K; Piolot T; Leroy O; Mariani O; Gronemeyer H; Vincent-Salomon A; Stern MH; Heard E
Genome Res; 2015 Apr; 25(4):488-503. PubMed ID: 25653311
[TBL] [Abstract][Full Text] [Related]
6. Association of BRCA1 with the inactive X chromosome and XIST RNA.
Ganesan S; Silver DP; Drapkin R; Greenberg R; Feunteun J; Livingston DM
Philos Trans R Soc Lond B Biol Sci; 2004 Jan; 359(1441):123-8. PubMed ID: 15065664
[TBL] [Abstract][Full Text] [Related]
7. Abnormalities of the inactive X chromosome are a common feature of BRCA1 mutant and sporadic basal-like breast cancer.
Ganesan S; Richardson AL; Wang ZC; Iglehart JD; Miron A; Feunteun J; Silver D; Livingston DM
Cold Spring Harb Symp Quant Biol; 2005; 70():93-7. PubMed ID: 16869742
[TBL] [Abstract][Full Text] [Related]
8. Barr body in fine needle aspiration cytology of ovarian malignancies.
Agrawal P; Dey P
Diagn Cytopathol; 2012 Nov; 40(11):964-6. PubMed ID: 21416650
[TBL] [Abstract][Full Text] [Related]
9. X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors.
Vincent-Salomon A; Ganem-Elbaz C; Manié E; Raynal V; Sastre-Garau X; Stoppa-Lyonnet D; Stern MH; Heard E
Cancer Res; 2007 Jun; 67(11):5134-40. PubMed ID: 17545591
[TBL] [Abstract][Full Text] [Related]
10. Heterozygote BRCA1 status and skewed chromosome X inactivation.
Helbling-Leclere A; Lenoir GM; Feunteun J
Fam Cancer; 2007; 6(1):153-7. PubMed ID: 16944269
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability.
Slee RB; Steiner CM; Herbert BS; Vance GH; Hickey RJ; Schwarz T; Christan S; Radovich M; Schneider BP; Schindelhauer D; Grimes BR
Oncogene; 2012 Jul; 31(27):3244-53. PubMed ID: 22081068
[TBL] [Abstract][Full Text] [Related]
12. The facultative heterochromatin of the inactive X chromosome has a distinctive condensed ultrastructure.
Rego A; Sinclair PB; Tao W; Kireev I; Belmont AS
J Cell Sci; 2008 Apr; 121(Pt 7):1119-27. PubMed ID: 18334550
[TBL] [Abstract][Full Text] [Related]
13. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
14. Nonequivalent gene expression and copy number alterations in high-grade serous ovarian cancers with BRCA1 and BRCA2 mutations.
George J; Alsop K; Etemadmoghadam D; Hondow H; Mikeska T; Dobrovic A; deFazio A; ; Smyth GK; Levine DA; Mitchell G; Bowtell DD
Clin Cancer Res; 2013 Jul; 19(13):3474-84. PubMed ID: 23633455
[TBL] [Abstract][Full Text] [Related]
15. [A paradox and three egnimas about the role of BRCA1 in breast and ovarian cancers].
Feunteun J
J Soc Biol; 2004; 198(2):123-6. PubMed ID: 15368961
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitinated proteins including uH2A on the human and mouse inactive X chromosome: enrichment in gene rich bands.
Smith KP; Byron M; Clemson CM; Lawrence JB
Chromosoma; 2004 Dec; 113(6):324-35. PubMed ID: 15616869
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.
Wu JY; Vlastos AT; Pelte MF; Caligo MA; Bianco A; Krause KH; Laurent GJ; Irminger-Finger I
Int J Cancer; 2006 Mar; 118(5):1215-26. PubMed ID: 16152612
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of X chromosome inactivation in high grade ovarian serous adenocarcinoma.
Kang J; Lee HJ; Kim J; Lee JJ; Maeng LS
PLoS One; 2015; 10(3):e0118927. PubMed ID: 25742136
[TBL] [Abstract][Full Text] [Related]
19. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic.
Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL
J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778
[TBL] [Abstract][Full Text] [Related]
20. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
